Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irofulven and Oxaliplatin in advanced solid tumors
NCT00374660Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jun 2003
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irofulven in liver cancer, pancreatic cancer (PC), endometrial cancer (EC), gastric cancer (GC), prostate cancer (PCa), sponsored by Eisai Co., Ltd.. Started Jun 2003; status: completed.
02
Drugs
irofulven
03
Conditions
liver cancerpancreatic cancer (PC)endometrial cancer (EC)gastric cancer (GC)prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00374660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00374660.